ArticleEuropean journal of pain (London, England)2025

ART26.12, a novel fatty acid-binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models.

W G Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.